Good news for cannabis stocks, but European markets down
Published 04-DEC-2020 10:33 A.M.
2 minute read
Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.
In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.
The below articles were written under our previous business model. We have kept these articles online here for your reference.
Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.
Click Here to View Latest Articles
Cannabis stocks were celebrating this week, on the news that the United Nation’s Commission for Narcotic Drugs voted to reschedule cannabis. This means cannabis is effectively removed from a list including ‘hard’ drugs, such as heroin.
Only one member state rejected the move, however most Western countries, voted in favour of the proposal.
This comes almost two years after the World Health Organisation (WHO) recommended the rescheduling of cannabis and cannabis-related substances.
In general market news, Chris Beauchamp, Chief Market Analyst at IG says, “A slew of dour PMI readings has weighed on sentiment in European trading, while in London Rolls-Royce is enjoying a rebound after news of a new push into narrow-body aircraft.
“A more cautious mood has descended on stock markets in Europe this morning, after final PMI readings provided a less than stellar outlook for the region.
“The rash of figures confirmed the pessimistic near-term view of the eurozone economy and for the UK as well, as service sectors across the continent remain in contraction territory.
“Losses on stock markets are still relatively modest, since like the downturn earlier in the year, today’s figures have very much been a reflection of existing information – everyone can see it will have been tough month thanks to lockdown measures bearing down on economic performance.
“Stock markets continue instead to look for an upside case to support further gains from their current levels, but despite talk of progress on US stimulus, the EU recovery fund and Brexit, nothing as yet has appeared that can really galvanise investors into piling back into equities.
“Rolls-Royce has always managed to demonstrate a capacity to adapt to even the toughest times, and today’s announcement about a move back towards the narrow-body jetliner market has provided the spark the shares have been searching for in order to maintain their rebound from the November lows.
“The shares have only recouped around a third of their losses from late October, and the bounce since the beginning of November is perhaps only the latest in a series of false dawns for a share price that has yet to find a low.”
S&P 500: -0.06%
FTSE 100: + 0.42%
DAX: - 0.45%
CAC 40: - 0.15%
Asia Dow: + 0.54%
Nikkei 225: + 0.03%
Hang Seng: + 0.74%
ASX 200: + 0.38%
tagsCANNABIS STOCKS UNITED NATIONS COMMISSION ON NARCOTIC DRUGS WORLD HEALTH ORGANISATION EUROPEAN MARKETS
General Information Only
S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.
Conflicts of Interest Notice
S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.
Publication Notice and Disclaimer
The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.
Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.
This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.